XOMA Co. (NASDAQ:XOMAO) Sees Large Decrease in Short Interest

XOMA Co. (NASDAQ:XOMAO) was the recipient of a large drop in short interest in the month of January. As of January 15th, there was short interest totalling 2,500 shares, a drop of 34.2% from the December 31st total of 3,800 shares. Based on an average trading volume of 3,000 shares, the days-to-cover ratio is presently 0.8 days.

XOMA Price Performance

Shares of NASDAQ:XOMAO opened at $25.33 on Wednesday. XOMA has a 12-month low of $24.42 and a 12-month high of $25.87. The firm has a fifty day moving average of $25.41 and a two-hundred day moving average of $25.41.

About XOMA

XOMA Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets.